OVERVIEW
The INVEGA® PATHWAY was created to provide its sales force with a strategically sound method of simultaneously promoting three long-acting injectables (LAI) treatments. The PATHWAY includes 1-month, 3-month, and the first and only 6-month treatment options for adult patients with schizophrenia.
CATEGORY
Pharmaceutical Product Marketing
Pharmaceutical Product Marketing
AUDIENCE
HCP
HCP
AGENCY
DiD Agency / LUCID Group
DiD Agency / LUCID Group
CLIENT
J&J Innovative Medicines
J&J Innovative Medicines
ROLE
ACD, Art Direction & Design
ACD, Art Direction & Design